United States Electromyogram Monitoring Market Report 2019-2025 Featuring Natus Medical, Nihon Kohden, Cadwell Laboratories, Ambu, Neuroelectrics, & Shimmer and Spes Medica - ResearchAndMarkets.com

The "Electromyogram
Monitoring Market Report - United States - 2019-2025" report
has been added to ResearchAndMarkets.com's offering.

New electrodiagnostic EMG device purchases will be modest, driven
primarily by replacement sales, and alternate care sites are expected to
show little demand moving forward. However, sales of consumables are
expected to continue to rise and cause the market to grow towards the
end of the forecast period. Competitive price cutting by vendors will
continue to temper growth potential within the market, offset in part by
the established installed base and increasing procedural volumes.

Electromyography (EMG) devices measure the electrical activity in
muscles and the functionality of the nervous system to find the cause of
muscle malfunctions. Disorders causing nerve impairment can affect
muscle function, due to improper firing of electrical pulses. Some
examples of nervous system complications include amyotrophic lateral
sclerosis (ALS), carpal tunnel syndrome and myasthenia gravis (MG). EMG
monitoring and diagnostic capabilities are limited to nerve and muscle
function and are not able to diagnose brain or spinal cord diseases.

Key Topics Covered:

1. Executive Summary

U.S. Patient Monitoring Equipment Market Overview

Competitive Analysis

Market Trends

Market Developments

Markets Included

Key Report Updates

Version History

Research Methodology

2. Electromyogram Monitoring Market

2.1 Introduction

2.1.1 Neuropathy

2.1.2 Myopathy

2.1.3 Applications

2.1.4 Complications

2.2 Market Overview

2.3 Market Analysis And Forecast

2.3.1 Total EMG Monitor Market

2.3.1.1 Hospital EMG Monitor Market

2.3.1.2 Alternate Care EMG Monitor Market

2.3.2 Total EMG Consumables Market

2.3.2.1 EMG Concentric Needle Market

2.3.2.2 EMG Monopolar Needle Market

2.3.2.3 EMG Surface Electrode Market

2.4 Drivers And Limiters

2.5 Competitive Market Share Analysis

3. Abbreviations

4. Appendix: Company Press Releases

4.1 Introduction

4.2 Press Releases

4.2.1 Draeger Medical

4.2.1.1 First half of 2018: Dräger increases net sales

4.2.1.2 New HealthTrust Agreement Covers Dräger's Line of Anesthesia
Solutions

4.2.1.3 Dräger and ICON Prepared to Support Hospitals with Ventilators
During Times of Crisis

4.2.1.4 Dräger First to Achieve DIACAP Certification for Patient
Monitoring and Clinical IT Systems

4.2.1.5 Dräger Infinity M300 Monitor Now Features FIPS Security

4.2.1.6 Dräger First to Achieve DIACAP Certification for Patient
Monitoring and Clinical IT Systems

4.2.1.7 Dräger to Discuss Alarm Management and Strategies for
Eliminating Alarm Fatigue at HIMSS16

4.2.2 Edwards Lifesciences

4.2.2.1 Edwards Lifesciences Reports Second Quarter Results

4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S.

4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results

4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor
Conference

4.2.2.5 Edwards Acquires Harpoon Medical

4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA
Clearance

4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results

4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio

4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator

4.2.2.10 Edwards Lifesciences Reports Second Quarter Results

4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of
Directors

4.2.2.12 Edwards Lifesciences Reports First Quarter Results

4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of
Directors

4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results

4.2.3 Fukuda Denshi

4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound
System in the U.S. A High Performance Color Portable Ultrasound Unit
Designed for a Wide Array of Specialty Markets

4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi
USA Inc. and Amerinet Choice License and Supply Agreement

4.2.4 GE Healthcare

4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare
Technology Management Professionals

4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body
composition analysis software for sports and fitness markets

4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the
Heart Station Beyond the Hospital

4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and
Workforce Management Software Unit from GE Healthcare for $1 Billion

4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver
comprehensive training program for Maternal, Newborn & Child Health
(MNCH)

4.2.4.6 Ministry of Health and GE delivering digital solutions to bring
transformative change to Kingdom's healthcare sector

4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital
Diagnostics Platform to Improve Oncology and Critical Care Treatment

4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care
Delivery Costs by $182 Million over Six Years

Companies Mentioned

• Natus Medical
• Nihon Kohden
• Cadwell Laboratories
• Ambu
• Neuroelectrics
• Shimmer and Spes Medica

For more information about this report visit https://www.researchandmarkets.com/research/bcxqnt/united_states?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190403005523/en/